Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             78 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ACP releases guidelines for fracture prevention in osteoporosis 2008
1657 1 p. 3
artikel
2 Adecatumumab an advantage for some with MBC 2008
1657 1 p. 10
artikel
3 ADRs to local anaesthetics: review of French database 2008
1657 1 p. 21
artikel
4 Alemtuzumab shows further benefits over INF-β-1b for RRMS 2008
1657 1 p. 11
artikel
5 Alitretinoin approved in Denmark. 2008
1657 1 p. 21
artikel
6 All eyes on candesartan in diabetes: new results from DIRECT 2008
1657 1 p. 15
artikel
7 Anti-atherogenic approach with irbesartan/pravastatin? 2008
1657 1 p. 18
artikel
8 Anticoagulant sales likely to double over next decade 2008
1657 1 p. 22
artikel
9 Atropine prevents, reverses negative chronotropic effect of fingolimod 2008
1657 1 p. 8
artikel
10 BA 210 granted orphan drug status in the EU. 2008
1657 1 p. 22
artikel
11 Bicalutamide receives additional exclusivity in the US. 2008
1657 1 p. 22
artikel
12 Botulinum toxin A a no-brainer for chronic migraine 2008
1657 1 p. 14
artikel
13 Bucindolol BEST in HF patients with `very favourable' genotypes 2008
1657 1 p. 10
artikel
14 Can clinical research ever be truly independent? 2008
1657 1 p. 3
artikel
15 Cetuximab extends survival in patients with mCRC 2008
1657 1 p. 14
artikel
16 Cetuximab failure means bevacizumab still best biologic 2008
1657 1 p. 16
artikel
17 Cetuximab improves OS in head and neck cancer 2008
1657 1 p. 17
artikel
18 Cetuximab launched in Japan for advanced colorectal cancer 2008
1657 1 p. 23
artikel
19 Chronic migraine still cramping patients' style 2008
1657 1 p. 5
artikel
20 Cinacalcet improves BMD in renal transplant recipients with hyperparathyroidism 2008
1657 1 p. 16
artikel
21 Consolidative immunotherapy in chemoresponsive sarcomas 2008
1657 1 p. 8
artikel
22 Continuous adalimumab most beneficial in psoriasis 2008
1657 1 p. 14
artikel
23 Crofelemer effective in the treatment of cholera 2008
1657 1 p. 13
artikel
24 Denosumab STANDs to give patients FREEDOM to DECIDE 2008
1657 1 p. 7-8
artikel
25 Encouraging results with EndoTAG-1 in pancreatic cancer 2008
1657 1 p. 10
artikel
26 Enzyme replacement therapy granted orphan drug designation. 2008
1657 1 p. 21
artikel
27 Everolimus NETs RADIANT results in phase II trial 2008
1657 1 p. 17
artikel
28 Everolimus + octreotide promising in neuroendocrine tumours 2008
1657 1 p. 10
artikel
29 Everolimus sets new RECORDs for advanced renal cancer 2008
1657 1 p. 18
artikel
30 Fingolimod finds favour in MS 2008
1657 1 p. 12
artikel
31 Fougera's generic antifungal cream approved by US FDA. 2008
1657 1 p. 22
artikel
32 Further evidence for fampridine use in treating MS 2008
1657 1 p. 9
artikel
33 Further findings for interferon-beta-1a in RRMS 2008
1657 1 p. 17
artikel
34 Generic alendronic acid given the OK in the US. 2008
1657 1 p. 22
artikel
35 Generic levodopa/carbidopa approved in the US. 2008
1657 1 p. 22
artikel
36 Generic protriptyline tablets approved in US. 2008
1657 1 p. 22
artikel
37 Generic version of Janssen's Risperdal approved in the US. 2008
1657 1 p. 22
artikel
38 Gene therapy holds hope for Duchenne muscular dystrophy 2008
1657 1 p. 8
artikel
39 Glatiramer acetate good news for MS 2008
1657 1 p. 16
artikel
40 Glycopyrrolate effective as treatment for sialorrhoea 2008
1657 1 p. 13
artikel
41 Golotimod shows encouraging antiviral activity in HCV 2008
1657 1 p. 12
artikel
42 Hypophosphataemia drug candidate gets orphan status in US. 2008
1657 1 p. 22
artikel
43 Inconclusive results for ispronicline in AD 2008
1657 1 p. 11
artikel
44 Increased mortality with epoetin-α in stroke patients 2008
1657 1 p. 19
artikel
45 Inhaled insulin blows away insulin injections 2008
1657 1 p. 16
artikel
46 Iobenguane approved for detection of rare endocrine tumours. 2008
1657 1 p. 23
artikel
47 Ipilimumab extends survival in advanced melanoma 2008
1657 1 p. 9
artikel
48 Longterm androgen deprivation therapy has a cost 2008
1657 1 p. 2
artikel
49 Long-term betacarotene improves memory 2008
1657 1 p. 18
artikel
50 Macromolecular polymer equivalent to heparin coating 2008
1657 1 p. 14
artikel
51 Maternal influenza immunisation pays off for mums and kids 2008
1657 1 p. 1
artikel
52 MF 101 promising for menopausal hot flashes 2008
1657 1 p. 8
artikel
53 More seeds of doubt sewn about integrity of big pharma 2008
1657 1 p. 2
artikel
54 Natalizumab in MS well tolerated 2008
1657 1 p. 18
artikel
55 New Canadian diabetes guidelines include DPP-IV inhibitors 2008
1657 1 p. 2
artikel
56 Nicardipine injection introduced in the US. 2008
1657 1 p. 22
artikel
57 Novel vaccine show promise for relapsing-remitting MS 2008
1657 1 p. 12
artikel
58 NX 1207 shows positive effect in BPH 2008
1657 1 p. 12
artikel
59 Odanacatib opportune for osteoporosis 2008
1657 1 p. 9
artikel
60 Olanzapine increases FASN and SCD gene expression in blood cells 2008
1657 1 p. 20
artikel
61 Paracetamol a risk factor for asthma in childhood? 2008
1657 1 p. 20
artikel
62 Paracetamol + ibuprofen best option in paediatric fever? 2008
1657 1 p. 4
artikel
63 Pazopanib a new weapon in the anti-cancer arsenal 2008
1657 1 p. 6
artikel
64 PharmacoEconomics issue on overcoming `fourth hurdle' (NICE) 2008
1657 1 p. 5
artikel
65 PPI interaction makes clopidogrel less effective 2008
1657 1 p. 20
artikel
66 Ranbaxy medicines come under scrutiny after FDA audit 2008
1657 1 p. 21
artikel
67 Sertraline improves depression, reduces HF mortality 2008
1657 1 p. 19
artikel
68 Silibinin reduces serum ferritin levels in chronic hepatitis C 2008
1657 1 p. 6
artikel
69 Solifenacin economically dominant in OAB 2008
1657 1 p. 4
artikel
70 Somatropin efficacy comparable with existing therapies 2008
1657 1 p. 16
artikel
71 Tafluprost reduces intraocular pressure in healthy volunteers 2008
1657 1 p. 8
artikel
72 The ORACLEs speak . . . and it is not good news 2008
1657 1 p. 19
artikel
73 TH 9402 receives orphan drug designation in EU. 2008
1657 1 p. 23
artikel
74 Trabectedin triumphs in ovarian cancer 2008
1657 1 p. 11
artikel
75 TT 223 phase II trial in type 2 diabetes underway 2008
1657 1 p. 13
artikel
76 Unit dose budesonide trial completes enrolment 2008
1657 1 p. 6
artikel
77 Vitamin B12 may protect the brain in old age 2008
1657 1 p. 6
artikel
78 Zoledronic acid shows potential anticancer benefits 2008
1657 1 p. 13
artikel
                             78 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland